Abstract
Objectives: The PEACH trial, which was a multicenter and randomized trial to evaluate the effects of lipid therapy on the progression of coronary calcium score (CCS), demonstrated that annual progression rate of Agatston score was 40% in whole patients irrespective of a significant reduction of LDL-C. The number of circulating CD34 positive cell was reported to be associated with cardiovascular risks. We examined the association the baseline number of CD34 positive cell and annual progression of CCS.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
